Allele-specific induction of IL-1β expression by C/EBPβ and PU.1 contributes to increased tuberculosis susceptibility.
Allele-specific induction of IL-1β expression by C/EBPβ and PU.1 contributes to increased tuberculosis susceptibility.
复制标题
DOI:
10.1371/journal.ppat.1004426
复制
发表时间:
2014-10
期刊:
影响因子:
6.7
通讯作者:
Chen X
中科院分区:
文献类型:
--
作者:
Zhang G;Zhou B;Li S;Yue J;Yang H;Wen Y;Zhan S;Wang W;Liao M;Zhang M;Zeng G;Feng CG;Sassetti CM;Chen X
Mycobacterium tuberculosis infection is associated with a spectrum of clinical outcomes, from long-term latent infection to different manifestations of progressive disease. Pro-inflammatory pathways, such as those controlled by IL-1β, have the contrasting potential both to prevent disease by restricting bacterial replication, and to promote disease by inflicting tissue damage. Thus, the ultimate contribution of individual inflammatory pathways to the outcome of M. tuberculosis infection remains ambiguous. In this study, we identified a naturally-occurring polymorphism in the human IL1B promoter region, which alters the association of the C/EBPβ and PU.1 transcription factors and controls Mtb-induced IL-1β production. The high-IL-1β expressing genotype was associated with the development of active tuberculosis, the severity of pulmonary disease and poor treatment outcome in TB patients. Higher IL-1β expression did not suppress the activity of IFN-γ-producing T cells, but instead correlated with neutrophil accumulation in the lung. These observations support a specific role for IL-1β and granulocytic inflammation as a driver of TB disease progression in humans, and suggest novel strategies for the prevention and treatment of tuberculosis. IL-1β is important for the initial establishment of antimicrobial adaptive immunity, but prolonged IL-1β expression can also cause progressive immunopathology during M. tuberculosis infection. The paradoxical activities of IL-1β in promoting both antimycobacterial immunity and chronic tissue damage have left the ultimate contribution of this cytokine to TB progression in human populations unclear. In this work, we address the role of IL-1β-mediated inflammation using a combination of human genetics and molecular biology, and suggest that exuberant IL-1β responses are causatively associated with TB progression and poor treatment outcome in humans. This work furthers our understanding of the immunological factors that underlie TB disease and provide a strong rationale for the development of specific anti-inflammatory adjunctive therapies that could improve the long-term outcome of TB treatment. In addition, these insights inform the design of future TB control efforts that include the rational design of disease-preventing vaccines and genotype-targeted delivery of TB chemotherapy.
登录
查看更多内容
影响因子:
--
作者:
El Baghdadi, J.;Grant, A-V;Sabri, A.;El Azbaoui, S.;Zaidi, H.;Cobat, A.;Schurr, E.;Boisson-Dupuis, S.;Casanova, J-L;Abel, L.
通讯作者:
Abel, L.
DOI:
10.1179/096805105x58706
发表时间:
2005-01-01
期刊:
JOURNAL OF ENDOTOXIN RESEARCH
影响因子:
--
作者:
Awomoyi, AA;Charurat, M;Newport, MJ
通讯作者:
Newport, MJ
影响因子:
5.5
作者:
Jurado, Javier O.;Pasquinelli, Virginia;Garcia, Veronica E.
通讯作者:
Garcia, Veronica E.
影响因子:
5.4
作者:
Caccamo, Nadia;Guggino, Giuliana;Dieli, Francesco
通讯作者:
Dieli, Francesco
DOI:
10.1084/jem.20090067
发表时间:
2010-04-12
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Dorhoi A;Desel C;Yeremeev V;Pradl L;Brinkmann V;Mollenkopf HJ;Hanke K;Gross O;Ruland J;Kaufmann SH
通讯作者:
Kaufmann SH